ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 10 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 20 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 40 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 80 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

ישראל - עברית - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; icodextrin; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - icodextrin 75 g/l; magnesium chloride hexahydrate 0.051 g/l; calcium chloride dihydrate 0.257 g/l; sodium (s) - lactate 4.5 g/l; sodium chloride 5.4 g/l - dextran - dextran - once daily replacement of a single glucose exchange as part of continuous ambulatory peritoneal dialysis (capd) or automated peritoneal dialysis (apd) in the treatment of chronic renal failure.

ישראל - עברית - Ministry of Health

omrix biopharmaceuticals ltd, israel - calcium chloride; protein clottable; thrombin - תמיסה - thrombin 800 - 1200 iu / 1 ml; calcium chloride 5.6 - 6.20 mg / 1 ml; protein clottable 50 - 90 mg / 1 ml - combinations - combinations - general haemostasis : evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. efficacy has been demonstrated in liver surgery and orthopaedic surgery.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - calcium chloride; potassium chloride; sodium chloride; sodium lactate - תמיסה לאינפוזיה - sodium chloride 6 g/l; potassium chloride 0.4 g/l; calcium chloride 0.27 g/l; sodium lactate 3.12 g/l - electrolytes - electrolytes - fluid and electrolytes replacement.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - calcium chloride; lactic acid as sodium; potassium chloride; sodium chloride - תמיסה להזרקה - sodium chloride 6 g/l; potassium chloride 0.3 g/l; calcium chloride 0.2 g/l; lactic acid as sodium 3.1 g/l - electrolytes with carbohydrates - electrolytes with carbohydrates - as a supply of water, for administration of electrolytes or calories, or as an alkalinizing agent.

ישראל - עברית - Ministry of Health

teva medical ltd - calcium chloride dihydrate; dextrose hydrous; lactic acid as sodium; magnesium chloride hexahydrate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - lactic acid as sodium 448 mg / 100 ml; magnesium chloride hexahydrate 5.08 mg / 100 ml; calcium chloride dihydrate 25.7 mg / 100 ml; sodium chloride 538 mg / 100 ml; dextrose hydrous 1.5 g / 100 ml - combinations - combinations - indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

ישראל - עברית - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - תמיסה לדיאליזה פריטוניאלית - glucose hydrous 1.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.